Ftse Mib
34.507,84
0,68%
DAX
18.575,94
0,86%
S&P 500
5.354,03
1,18%
NASDAQ
17.187,90
1,96%
Bitcoin
71.050,96
-0,04%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Virax Biolabs Group Ltd (VRAX) Virax Biolabs Group Ltd (VRAX) Notizie

VRAX

Virax Biolabs (VRAX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:VRAX
DataOraFonteTitoloSimboloCompagnia
25/04/202414:00PR Newswire (US)Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024NASDAQ:VRAXVirax Biolabs Group Ltd
16/04/202413:30PR Newswire (US)Virax Biolabs to Participate at ESCMID Global 2024NASDAQ:VRAXVirax Biolabs Group Ltd
15/03/202421:30PR Newswire (US)Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price DeficiencyNASDAQ:VRAXVirax Biolabs Group Ltd
22/01/202423:28Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
22/01/202423:27Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:VRAXVirax Biolabs Group Ltd
21/12/202313:30PR Newswire (US)Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID PatientsNASDAQ:VRAXVirax Biolabs Group Ltd
20/12/202322:12Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VRAXVirax Biolabs Group Ltd
18/12/202313:30PR Newswire (US)Virax Biolabs' CEO James Foster Issues Letter to ShareholdersNASDAQ:VRAXVirax Biolabs Group Ltd
18/12/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VRAXVirax Biolabs Group Ltd
14/12/202313:30PR Newswire (US)Virax Biolabs Group Limited Announces 1-for-10 Share ConsolidationNASDAQ:VRAXVirax Biolabs Group Ltd
05/12/202322:06Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:VRAXVirax Biolabs Group Ltd
17/10/202322:05Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:VRAXVirax Biolabs Group Ltd
12/09/202313:30PR Newswire (US)Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts WebinarNASDAQ:VRAXVirax Biolabs Group Ltd
01/09/202313:30PR Newswire (US)Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth MomentumNASDAQ:VRAXVirax Biolabs Group Ltd
03/08/202313:30PR Newswire (US)Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 BidNASDAQ:VRAXVirax Biolabs Group Ltd
18/07/202313:30PR Newswire (US)Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory FacilitiesNASDAQ:VRAXVirax Biolabs Group Ltd
14/06/202322:32Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:VRAXVirax Biolabs Group Ltd
14/06/202314:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:VRAXVirax Biolabs Group Ltd
04/05/202313:30PR Newswire (US)Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science ParkNASDAQ:VRAXVirax Biolabs Group Ltd
19/04/202313:30PR Newswire (US)Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing KitsNASDAQ:VRAXVirax Biolabs Group Ltd
31/03/202322:11Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:VRAXVirax Biolabs Group Ltd
31/03/202312:20Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VRAXVirax Biolabs Group Ltd
22/03/202314:41Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1)NASDAQ:VRAXVirax Biolabs Group Ltd
15/03/202321:16Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:VRAXVirax Biolabs Group Ltd
10/03/202323:17PR Newswire (US)Virax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq RulesNASDAQ:VRAXVirax Biolabs Group Ltd
08/03/202314:55PR Newswire (US)Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq RulesNASDAQ:VRAXVirax Biolabs Group Ltd
07/03/202313:30PR Newswire (US)Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test KitNASDAQ:VRAXVirax Biolabs Group Ltd
07/02/202314:30PR Newswire (US)Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)NASDAQ:VRAXVirax Biolabs Group Ltd
06/02/202322:05PR Newswire (US)Virax Biolabs to Present at the 2023 BIO CEO & Investor ConferenceNASDAQ:VRAXVirax Biolabs Group Ltd
04/01/202313:30PR Newswire (US)Virax Biolabs Introduces Human Papillomavirus ("HPV") Test KitNASDAQ:VRAXVirax Biolabs Group Ltd
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:VRAX

La tua Cronologia

COIN
MUSEUSD
Muse DAO
BIBX
GDXUSDT
Gridex
TSXV
TR
Troubadour Resources
COIN
VEILGBP
NYSE
CNF
CNFinance
LSE
CSH
Civitas Social Housing
USOTC
DTSOF
DTS (PK)
NYSE
TLK
Perusahaan Perseroan Per...
TSXV
TCEC
Tisdale Clean Energy
EU
CDCJP
Caisse des Depots et Con...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network